CELECOXIB

Celecoxib is a COX‑2 inhibitor reducing pain and inflammation with lower GI risk than NSAIDs. Side effects include cardiovascular risk, edema, and dyspepsia.

SKU: e2f85620f388 Category: Tag:

Product Description


Mechanism of Action

Celecoxib is a selective cyclo‑oxygenase‑2 (COX‑2) inhibitor that reduces synthesis of pro‑inflammatory prostaglandins while sparing COX‑1–mediated gastric protection and platelet aggregation. It reduces inflammation, pain signalling and vascular prostaglandin‑driven responses through reversible COX‑2 blockade and downstream reduction of prostaglandin E₂.

Benefits and Advantages

Used in inflammatory‑pathway research, COX‑2 selectivity modelling, prostaglandin synthesis studies, tumour‑microenvironment investigations, pain‑modulation assays and NSAID SAR profiling. Also applied in angiogenesis‑inhibition and cytokine‑regulation research.

Side Effects and Risks

Risks include cardiovascular events, renal impairment, fluid retention, GI irritation (reduced vs non‑selective NSAIDs), and rare hypersensitivity. Handle with NSAID‑class precautions.

Datasheet


Molecular Formula

C17H14F3N3O2S

Molecular Weight

381.4 g/mol

CAS Number

169590-42-5

Storage Condition

Keep container tightly closed in a dry and well-ventilated place.

Solubility

Poorly soluble

Purity

Purity information is available upon request (COA).

Synonym

celecoxib; 169590-42-5; Celebrex; Celebra; Onsenal

IUPAC/Chemical Name

4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

InChl Key

RZEKVGVHFLEQIL-UHFFFAOYSA-N

InChl Code

InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)

References

https://pubchem.ncbi.nlm.nih.gov/compound/2662;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download